Parishin Alleviates Pulmonary Fibrosis by Reducing CD38 Levels in Naturally Aging Mice
Rejuvenation Research · 2025-02 · 28 (1) · 25-32
DOI: 10.1089/rej.2024.0042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rejuvenation Research, online erschienen am 28.01.2025. Verfasst von Xinxiu Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Aging, Pulmonary Fibrosis, ADP-ribosyl Cyclase 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Parishin, a natural compound, has demonstrated significant potential in mitigating age-related phenotypes and improving outcomes in age-associated diseases. Given that aging is a major risk factor for numerous chronic conditions, including pulmonary fibrosis, we investigated parishin’s effects on cellular senescence and lung health. In our study, we treated mouse lung epithelial cells with parishin and observed a reduction in cellular senescence markers alongside an upregulation of sirtuin 1 (SIRT1). Building on these in vitro findings, we administered parishin to naturally aged mice. The treatment resulted in decreased pulmonary fibrosis and reduced DNA damage in lung tissue. Notably, we found that parishin treatment led to a reduction in Cluster of differentiation 38 (CD38) levels, concomitant with an increase in SIRT1 expression. These findings indicate that parishin may enhance lung function in aged mice, suggesting its potential as a therapeutic agent for treating age-related pulmonary disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Laboratory of Diagnosis and Treatment of Aging and Physic-chemical Injury Diseases of Zhejiang Province, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zitieren
APA
Zhao, X., Zhou, S., Sheng, Z., Sun, L., Zhang, Q., & Lu, Y. (2025). Parishin Alleviates Pulmonary Fibrosis by Reducing CD38 Levels in Naturally Aging Mice. Rejuvenation Research, 28(1), 25-32. https://doi.org/10.1089/rej.2024.0042
Vancouver
Zhao X, Zhou S, Sheng Z, Sun L, Zhang Q, Lu Y. Parishin Alleviates Pulmonary Fibrosis by Reducing CD38 Levels in Naturally Aging Mice. Rejuvenation Research. 2025;28(1):25-32. doi:10.1089/rej.2024.0042
BibTeX
@article{Zhao2025,
author = {Zhao, Xinxiu and Zhou, Shixian and Sheng, Zhaoying and Sun, Linlin and Zhang, Qin and Lu, Yuanqiang},
title = {Parishin Alleviates Pulmonary Fibrosis by Reducing CD38 Levels in Naturally Aging Mice},
journal = {Rejuvenation Research},
year = {2025},
volume = {28},
number = {1},
pages = {25--32},
doi = {10.1089/rej.2024.0042}
}
EUVIMED